vs
Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and Nextpower Inc. (NXT). Click either name above to swap in a different company.
Nextpower Inc. is the larger business by last-quarter revenue ($909.4M vs $493.8M, roughly 1.8× Pediatrix Medical Group, Inc.). Nextpower Inc. runs the higher net margin — 14.4% vs 6.8%, a 7.6% gap on every dollar of revenue. On growth, Nextpower Inc. posted the faster year-over-year revenue change (33.9% vs -1.7%). Over the past eight quarters, Nextpower Inc.'s revenue compounded faster (11.1% CAGR vs -0.1%).
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
Nextpower Inc. (NXT) is a global energy technology provider based in Fremont, California.
MD vs NXT — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $493.8M | $909.4M |
| Net Profit | $33.7M | $131.2M |
| Gross Margin | — | 31.7% |
| Operating Margin | 9.9% | 19.4% |
| Net Margin | 6.8% | 14.4% |
| Revenue YoY | -1.7% | 33.9% |
| Net Profit YoY | 10.5% | 13.8% |
| EPS (diluted) | $0.40 | $0.85 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $493.8M | $909.4M | ||
| Q3 25 | $492.9M | $905.3M | ||
| Q2 25 | $468.8M | $864.3M | ||
| Q1 25 | $458.4M | $924.3M | ||
| Q4 24 | $502.4M | $679.4M | ||
| Q3 24 | $511.2M | $635.6M | ||
| Q2 24 | $504.3M | $719.9M | ||
| Q1 24 | $495.1M | $736.5M |
| Q4 25 | $33.7M | $131.2M | ||
| Q3 25 | $71.7M | $146.9M | ||
| Q2 25 | $39.3M | $157.2M | ||
| Q1 25 | $20.7M | $156.8M | ||
| Q4 24 | $30.5M | $115.3M | ||
| Q3 24 | $19.4M | $115.4M | ||
| Q2 24 | $-153.0M | $121.7M | ||
| Q1 24 | $4.0M | $205.2M |
| Q4 25 | — | 31.7% | ||
| Q3 25 | — | 32.4% | ||
| Q2 25 | — | 32.6% | ||
| Q1 25 | — | 33.1% | ||
| Q4 24 | — | 35.5% | ||
| Q3 24 | — | 35.4% | ||
| Q2 24 | — | 33.0% | ||
| Q1 24 | — | 46.2% |
| Q4 25 | 9.9% | 19.4% | ||
| Q3 25 | 13.8% | 20.0% | ||
| Q2 25 | 12.8% | 21.5% | ||
| Q1 25 | 7.0% | 21.1% | ||
| Q4 24 | 7.8% | 22.1% | ||
| Q3 24 | 6.6% | 21.0% | ||
| Q2 24 | -31.3% | 22.2% | ||
| Q1 24 | 3.2% | 36.8% |
| Q4 25 | 6.8% | 14.4% | ||
| Q3 25 | 14.5% | 16.2% | ||
| Q2 25 | 8.4% | 18.2% | ||
| Q1 25 | 4.5% | 17.0% | ||
| Q4 24 | 6.1% | 17.0% | ||
| Q3 24 | 3.8% | 18.2% | ||
| Q2 24 | -30.3% | 16.9% | ||
| Q1 24 | 0.8% | 27.9% |
| Q4 25 | $0.40 | $0.85 | ||
| Q3 25 | $0.84 | $0.97 | ||
| Q2 25 | $0.46 | $1.04 | ||
| Q1 25 | $0.24 | $1.05 | ||
| Q4 24 | $0.37 | $0.79 | ||
| Q3 24 | $0.23 | $0.79 | ||
| Q2 24 | $-1.84 | $0.84 | ||
| Q1 24 | $0.05 | $1.52 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $375.2M | $952.6M |
| Total DebtLower is stronger | $570.5M | — |
| Stockholders' EquityBook value | $865.9M | $2.2B |
| Total Assets | $2.2B | $3.8B |
| Debt / EquityLower = less leverage | 0.66× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $375.2M | $952.6M | ||
| Q3 25 | $340.1M | $845.3M | ||
| Q2 25 | $224.7M | $743.4M | ||
| Q1 25 | $99.0M | $766.1M | ||
| Q4 24 | $229.9M | $693.5M | ||
| Q3 24 | $103.8M | $561.9M | ||
| Q2 24 | $19.4M | $471.9M | ||
| Q1 24 | $8.0M | $474.1M |
| Q4 25 | $570.5M | — | ||
| Q3 25 | $577.2M | — | ||
| Q2 25 | $583.9M | — | ||
| Q1 25 | $590.5M | — | ||
| Q4 24 | $597.1M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $865.9M | $2.2B | ||
| Q3 25 | $890.7M | $2.0B | ||
| Q2 25 | $833.8M | $1.8B | ||
| Q1 25 | $789.2M | $1.6B | ||
| Q4 24 | $764.9M | $1.4B | ||
| Q3 24 | $732.5M | $1.3B | ||
| Q2 24 | $706.5M | $1.1B | ||
| Q1 24 | $856.2M | $961.0M |
| Q4 25 | $2.2B | $3.8B | ||
| Q3 25 | $2.2B | $3.7B | ||
| Q2 25 | $2.1B | $3.4B | ||
| Q1 25 | $2.0B | $3.2B | ||
| Q4 24 | $2.2B | $3.0B | ||
| Q3 24 | $2.1B | $2.8B | ||
| Q2 24 | $2.0B | $2.6B | ||
| Q1 24 | $2.2B | $2.5B |
| Q4 25 | 0.66× | — | ||
| Q3 25 | 0.65× | — | ||
| Q2 25 | 0.70× | — | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | 0.78× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $114.1M | $123.3M |
| Free Cash FlowOCF − Capex | — | $118.5M |
| FCF MarginFCF / Revenue | — | 13.0% |
| Capex IntensityCapex / Revenue | — | 0.5% |
| Cash ConversionOCF / Net Profit | 3.39× | 0.94× |
| TTM Free Cash FlowTrailing 4 quarters | — | $587.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $114.1M | $123.3M | ||
| Q3 25 | $137.3M | $186.9M | ||
| Q2 25 | $137.2M | $81.3M | ||
| Q1 25 | $-117.5M | $237.3M | ||
| Q4 24 | $133.0M | $143.8M | ||
| Q3 24 | $91.8M | $153.8M | ||
| Q2 24 | $107.0M | $120.8M | ||
| Q1 24 | $-125.2M | $111.5M |
| Q4 25 | — | $118.5M | ||
| Q3 25 | — | $171.4M | ||
| Q2 25 | — | $70.1M | ||
| Q1 25 | — | $227.2M | ||
| Q4 24 | — | $134.9M | ||
| Q3 24 | — | $141.8M | ||
| Q2 24 | — | $118.0M | ||
| Q1 24 | — | $109.2M |
| Q4 25 | — | 13.0% | ||
| Q3 25 | — | 18.9% | ||
| Q2 25 | — | 8.1% | ||
| Q1 25 | — | 24.6% | ||
| Q4 24 | — | 19.9% | ||
| Q3 24 | — | 22.3% | ||
| Q2 24 | — | 16.4% | ||
| Q1 24 | — | 14.8% |
| Q4 25 | — | 0.5% | ||
| Q3 25 | — | 1.7% | ||
| Q2 25 | — | 1.3% | ||
| Q1 25 | — | 1.1% | ||
| Q4 24 | — | 1.3% | ||
| Q3 24 | — | 1.9% | ||
| Q2 24 | — | 0.4% | ||
| Q1 24 | — | 0.3% |
| Q4 25 | 3.39× | 0.94× | ||
| Q3 25 | 1.91× | 1.27× | ||
| Q2 25 | 3.49× | 0.52× | ||
| Q1 25 | -5.66× | 1.51× | ||
| Q4 24 | 4.36× | 1.25× | ||
| Q3 24 | 4.72× | 1.33× | ||
| Q2 24 | — | 0.99× | ||
| Q1 24 | -31.03× | 0.54× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
NXT
| Transferred Over Time | $763.9M | 84% |
| Transferred At Point In Time | $145.4M | 16% |
